Metoprolol Tartrate Injection, USP 5mg/5mL, vials, Rx only, MFG: Claris Lifesciences Inc., North Brunswick, NJ 08902, NDC# 70518-0868-00

FDA recall notice · announced November 21, 2018 · Remedyrepack

Class III FDA/FSIS Class III: use is not likely to cause adverse health consequences.

The product

Metoprolol Tartrate Injection, USP 5mg/5mL, vials, Rx only, MFG: Claris Lifesciences Inc., North Brunswick, NJ 08902, NDC# 70518-0868-00

Reason for recall

Failed pH Specifications: High Out-of-Specification results for pH were obtained during stability testing.

Notes

Distribution: 1 vial was distributed to a medical facility in Mayville, NY.
Lot/code information: Lot #: A0A0253, Exp. 02/2019; Lot #: B0369427-112717, Exp. 08/2019
Quantity: 1 vial
Status: Terminated
Products in this recall event:
- Metoprolol Tartrate Injection, USP 5mg/5mL, vials, Rx only, MFG: Claris Lifesciences Inc., North Brunswick, NJ 08902, NDC# 70518-0868-00 (D-0245-2019)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.